Feds to investigate nursing home abuse of antipsychotics
Headline from WTOP Washington DC
The federal government says it will begin a targeted crackdown on nursing homes’ abuse of antipsychotic drugs and misdiagnoses of schizophrenia in patients.
WTOP Washington DC's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
WEDNESDAY, Jan. 18, 2023 (HealthDay News) -- U.S. health officials say they plan to investigate whether some nursing homes are falsely labeling patients as schizophrenic so they can administer sedating
The federal government says it will begin a targeted crackdown on nursing homes’ abuse of antipsychotic drugs and misdiagnoses of schizophrenia in patients.
Evidence suggests some facilities wrongly diagnose residents with schizophrenia or administer antipsychotic drugs to sedate them, despite dangerous side effects
The Centers for Medicare and Medicaid Services announced a new initiative to audit nursing homes to determine if they are inappropriately dispensing antipsychotic medication to residents.
The Biden administration is planning to investigate the inappropriate use of certain antipsychotic drugs and wrongful diagnoses of schizophrenia in nursing homes as part of an initiative to crack down on misuse of medications that may cause dangerous side effects.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Feds to investigate nursing home abuse of antipsychotics | Since Then
